considerations in the management of alk nsclc
Published 5 years ago • 50 plays • Length 7:48Download video MP4
Download video MP3
Similar videos
-
4:23
alecensa: targeted therapy for alk-positive lung cancer
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
3:53
treatment considerations in non–small cell lung cancer
-
5:53
targeted therapy in non-small cell lung cancer
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
42:31
alk positive lung cancer in 2023 and beyond: thinking outside the box with dr. alice shaw
-
47:57
lung cancer new treatment 2023
-
1:28:28
alk 101 part 1: i've just been diagnosed with alk positive lung cancer
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
40:57
expanding her2 horizons: implications for nsclc and beyond
-
3:55
treatment considerations in alk/ros-1–rearranged nsclc
-
1:21
improvements in the treatment of alk nsclc
-
0:58
progress in the treatment of alk-positive non-small cell lung cancer
-
1:01
targeting alk rearrangements in non-small cell lung cancer
-
3:04
management of frontline alk nsclc: brigatinib vs. alectinib
-
9:00
fda d.i.s.c.o.: two approvals for alk-positive non-small cell lung cancer
-
3:26
key considerations in the management of stage 3 nsclc
-
0:53
any role of chemotherapy in high pdl1 metastatic non-small cell lung cancer in 1l?
-
1:01:24
integrating alk-targeted therapy into the management of localized non-small cell lung cancer
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc